What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary areas of investigation include Renal cell carcinoma, Carcinoma, Internal medicine, Surgery and Nephrectomy.
His Renal cell carcinoma research is multidisciplinary, relying on both Kidney, Radiology and Kidney disease.
The Carcinoma study combines topics in areas such as Adenocarcinoma, Disease, Stage, Primary tumor and Immunotherapy.
Arie S. Belldegrun has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study.
His work carried out in the field of Surgery brings together such families of science as Prostate, Epidemiology and Intensive care medicine.
His Nephrectomy research is multidisciplinary, incorporating perspectives in Survival rate, Predictive value of tests, Retrospective cohort study, Proportional hazards model and Univariate analysis.
His most cited work include:
- THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA (733 citations)
- Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy (593 citations)
- Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. (578 citations)
What are the main themes of his work throughout his whole career to date?
Arie S. Belldegrun mainly investigates Renal cell carcinoma, Internal medicine, Oncology, Pathology and Nephrectomy.
The study incorporates disciplines such as Carcinoma, Surgery, Kidney disease and Immunotherapy in addition to Renal cell carcinoma.
His studies in Carcinoma integrate themes in fields like Survival rate, Survival analysis, Performance status and Adenocarcinoma.
All of his Internal medicine and Nephrology, Cancer, Prostate cancer, Clear cell renal cell carcinoma and Stage investigations are sub-components of the entire Internal medicine study.
Arie S. Belldegrun combines subjects such as Metastasis, Clinical trial and Disease with his study of Oncology.
Arie S. Belldegrun has researched Nephrectomy in several fields, including Proportional hazards model and Urology.
He most often published in these fields:
- Renal cell carcinoma (47.39%)
- Internal medicine (42.16%)
- Oncology (28.92%)
What were the highlights of his more recent work (between 2010-2020)?
- Internal medicine (42.16%)
- Renal cell carcinoma (47.39%)
- Oncology (28.92%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Renal cell carcinoma, Oncology, Clear cell renal cell carcinoma and Surgery.
His Renal cell carcinoma research integrates issues from Carcinoma, Proportional hazards model, Nephrectomy and Immunotherapy.
His Carcinoma research is multidisciplinary, relying on both Kidney and Performance status.
His work carried out in the field of Nephrectomy brings together such families of science as Retrospective cohort study and Urology.
His Oncology study combines topics from a wide range of disciplines, such as Adjuvant therapy and Cohort.
Arie S. Belldegrun interconnects Body mass index, Overweight and Placebo in the investigation of issues within Surgery.
Between 2010 and 2020, his most popular works were:
- The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma. (94 citations)
- Tumor Biology and Prognostic Factors in Renal Cell Carcinoma (92 citations)
- Novel Therapeutic Strategies for Castration Resistant Prostate Cancer: Inhibition of Persistent Androgen Production and Androgen Receptor Mediated Signaling (89 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Arie S. Belldegrun mainly investigates Renal cell carcinoma, Internal medicine, Carcinoma, Oncology and Pathology.
The various areas that Arie S. Belldegrun examines in his Renal cell carcinoma study include Immunology, Proportional hazards model, Nephrectomy, Biomarker and Immunotherapy.
Internal medicine is frequently linked to Surgery in his study.
Kidney cancer is the focus of his Carcinoma research.
His research in Oncology intersects with topics in Stage, Gynecology and Adjuvant therapy.
His Clear cell renal cell carcinoma study in the realm of Pathology connects with subjects such as Grading.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
